[Essential hypertension].
Murakami
Hideyuki
H
Second Department of Internal Medicine, Sapporo Medical University School of Medicine.
Shimamoto
Kazuaki
K
D000493:Allopurinol / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001553:Benzbromarone / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D033461:Hyperuricemia / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D007333:Insulin Resistance; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000209:etiology; D014528:Uricosuric Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D014528:Uricosuric Agents; D001553:Benzbromarone; D000493:Allopurinol